Cargando…
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma
BACKGROUND: As a novel treatment, programmed cell death protein 1 (PD-1) inhibitor appears to be less effective in tumors of lung adenocarcinoma patients with epidermal growth factor receptor (EGFR) mutation. Beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3) has reported to be associated with prog...
Autores principales: | Leng, Xuefeng, Wei, Shiyou, Mei, Jiandong, Deng, Senyi, Yang, Zhenyu, Liu, Zheng, Guo, Chenglin, Deng, Yulan, Xia, Liang, Cheng, Jiahan, Zhao, Kejia, Gan, Fanyi, Li, Chuan, Merrell, Kenneth W., Molina, Julian R., Metro, Giulio, Liu, Lunxu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947420/ https://www.ncbi.nlm.nih.gov/pubmed/33718036 http://dx.doi.org/10.21037/tlcr-21-146 |
Ejemplares similares
-
Tumor-Infiltrating PD-1(hi)CD8(+)-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers
por: Yang, Zhenyu, et al.
Publicado: (2021) -
Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway
por: Cheng, Jiahan, et al.
Publicado: (2022) -
Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer
por: Gan, Fanyi, et al.
Publicado: (2022) -
Identifies Immune Feature Genes for Prediction of Chemotherapy Benefit in Cancer
por: Bai, Yuquan, et al.
Publicado: (2022) -
Construction and investigation of β3GNT2-associated regulatory network in esophageal carcinoma
por: Luo, Zhiguo, et al.
Publicado: (2022)